Summary of UnitedHealth Group Q1 2026 Earnings Call

1Key Financial Results and Metrics

Adjusted Earnings Per Share (EPS): Reported at $7.23, exceeding expectations.

Total Revenues: $111.7 billion, reflecting a 2% year-over-year growth.

Total Members: 49.1 million, down from 49.8 million at the end of 2025.

Medical Care Ratio: 83.9%, improved from 84.8% in Q1 2025, driven by pricing discipline and favorable reserve development.

Operating Cost Ratio: 13.8%, influenced by investments in technology and operations.

Operating Cash Flows: Strong at $8.9 billion, or 1.4x net income.

Debt-to-Capital Ratio: Reduced to 42.9%, with a target of 40% by year-end.

2Strategic Updates and Business Highlights

Business Segment Performance: All major segments exceeded plans, with UnitedHealthcare showing improved pricing and operational performance.

Optum Health: Adjusted earnings of $1.3 billion, reflecting operational improvements and disciplined value-based care practices.

AI Investments: Committed to investing $1.5 billion in AI initiatives in 2026, aimed at enhancing operational efficiency and consumer experience.

Community Engagement: Increased focus on rural health care, maternal and children's health, and behavioral health through the United Health Foundation.

Governance Enhancements: Strengthened corporate governance with new leadership roles and a Public Responsibility Committee.

3Forward Guidance and Outlook

Full-Year EPS Guidance: Updated to greater than $18.25, balancing strong Q1 performance with cautious optimism for the remainder of the year.

Membership Expectations: Anticipated contraction of approximately 1.3 million members, particularly in the ACA market.

Medicare Advantage: Expected to achieve a 50 basis point year-over-year margin advance in 2026, with aspirations for upper half performance in the 2-4% long-term margin range by 2027.

4Bad News, Challenges, or Points of Concern

Medicaid Pressures: Continued challenges in state-based rate environments, with expectations of membership attrition and negative margins in 2026.

Commercial Business: Membership growth is moderated due to pricing actions, with the individual ACA business expected to contract significantly.

High Medical Trends: Elevated medical cost trends persist, particularly in Medicare Advantage, with no immediate inflection points observed.

Regulatory Risks: Potential impacts from proposed Medicare Advantage risk model recalibrations and ongoing legislative changes affecting PBM operations.

5Notable Q&A Insights

Cost Trends: Medicare Advantage cost trends remain elevated, with a focus on managing acuity and provider billing.

Optum Health Performance: Strong performance attributed to intentional operational improvements and clinical management, with expectations for continued momentum.

AI Impact: Investments in AI are expected to yield significant long-term productivity gains, though specific financial impacts remain unquantified at this stage.

PBM Legislation: Concerns regarding new legislation in Tennessee affecting access to specialty pharmacies, with a commitment to advocate for affected populations.

PDR and Value-Based Care: Ongoing negotiations regarding PDRs, with confidence in expanding value-based care offerings despite potential reimbursement cuts in chronic condition codes. Overall, UnitedHealth Group reported a solid start to 2026, with strong financial performance and strategic initiatives aimed at enhancing operational efficiency and community health, while navigating challenges in certain segments and external regulatory pressures.